======= FTSJ1 =======
== Gene Information ==
* **Official Symbol**: FTSJ1
* **Official Name**: FtsJ RNA 2'-O-methyltransferase 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=24140|24140]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UET6|Q9UET6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=FTSJ1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FTSJ1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/300499|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the methyltransferase superfamily. The encoded protein localizes to the nucleolus, binds to S-adenosylmethionine, and may be involved in the processing and modification of ribosomal RNA. Mutations in this gene are associated with cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013].
* **UniProt Summary**: Methylates the 2'-O-ribose of nucleotides at positions 32 and 34 of the tRNA anticodon loop of substrate tRNAs. {ECO:0000255|HAMAP-Rule:MF_03162}.
|FtsJ|
|tRNA nucleoside ribose methylation|
|tRNA (guanosine-2-O-)-methyltransferase activity|
|tRNA (cytosine-2-O-)-methyltransferase activity|
|tRNA methyltransferase activity|
|tRNA methylation|
|cytoplasmic translation|
|RNA methylation|
|tRNA modification|
|tRNA processing|
|RNA modification|
|tRNA metabolic process|
|macromolecule methylation|
|methylation|
|translation|
|ncRNA processing|
|peptide biosynthetic process|
|ncRNA metabolic process|
|amide biosynthetic process|
|peptide metabolic process|
|cellular amide metabolic process|
|RNA processing|
|organonitrogen compound biosynthetic process|
|cellular nitrogen compound biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|-2.44|
|[[:results:exp453|B02 10μM R08 exp453]]|-2.08|
|[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-2.05|
|[[:results:exp236|GSK2606414 1μM R05 exp236]]|-2.03|
|[[:results:exp147|Resveratrol 16μM R03 exp147]]|-1.95|
|[[:results:exp409|THZ531 0.11μM R07 exp409]]|-1.82|
|[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-1.73|
|[[:results:exp280|Daidzin 10μM R06 exp280]]|-1.73|
|[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|-1.73|
|[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.94|
^Gene^Correlation^
|[[:human genes:g:gtpbp2|GTPBP2]]|0.408|
|[[:human genes:r:rnaseh2b|RNASEH2B]]|0.406|
Global Fraction of Cell Lines Where Essential: 0/694
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/26|
|bone|0/26|
|breast|0/30|
|central nervous system|0/49|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/11|
|fibroblast|0/1|
|gastric|0/14|
|kidney|0/18|
|liver|0/19|
|lung|0/72|
|lymphocyte|0/16|
|ovary|0/25|
|pancreas|0/22|
|peripheral nervous system|0/15|
|plasma cell|0/12|
|prostate|0/1|
|skin|0/20|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/28|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5643
* **Expression level (log2 read counts)**: 5.81
{{:chemogenomics:nalm6 dist.png?nolink |}}